Your browser doesn't support javascript.
loading
Impact of dose intensity of ponatinib on selected adverse events: Multivariate analyses from a pooled population of clinical trial patients.
Dorer, David J; Knickerbocker, Ronald K; Baccarani, Michele; Cortes, Jorge E; Hochhaus, Andreas; Talpaz, Moshe; Haluska, Frank G.
Afiliación
  • Dorer DJ; ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, MA, 02139-4234, USA. Electronic address: david.dorer@ariad.com.
  • Knickerbocker RK; ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, MA, 02139-4234, USA. Electronic address: ronald.knickerbocker@ariad.com.
  • Baccarani M; Department of Hematology and Oncology, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy. Electronic address: michele.baccarani@unibo.it.
  • Cortes JE; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 428, 77030, Houston, TX, USA. Electronic address: jcortes@mdanderson.org.
  • Hochhaus A; Department of Hematology and Medical Oncology, Jena University Hospital, Erlanger Allee 101, 07747, Jena, Germany. Electronic address: andreas.hochhaus@med.uni-jena.de.
  • Talpaz M; Division of Hematology/Oncology, Comprehensive Cancer Center, University of Michigan, 1500 East Medical Center Drive, Room 4302, Ann Arbor, MI, 48109-5936, USA. Electronic address: mtalpaz@med.umich.edu.
  • Haluska FG; ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, MA, 02139-4234, USA. Electronic address: frank.haluska@ariad.com.
Leuk Res ; 48: 84-91, 2016 09.
Article en En | MEDLINE | ID: mdl-27505637

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piridazinas / Leucemia Mielógena Crónica BCR-ABL Positiva / Imidazoles Tipo de estudio: Prognostic_studies Límite: Humans / Middle aged Idioma: En Revista: Leuk Res Año: 2016 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piridazinas / Leucemia Mielógena Crónica BCR-ABL Positiva / Imidazoles Tipo de estudio: Prognostic_studies Límite: Humans / Middle aged Idioma: En Revista: Leuk Res Año: 2016 Tipo del documento: Article